China SXT Pharmaceuticals (STU:2RY1) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2RY1 China SXT Pharmaceuticals Inc STU:2RY1
40 GF Score
Price €384.00
GF Value €2,263.37
! 8 Warning Signs
View Full Analysis

What is China SXT Pharmaceuticals Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

China SXT Pharmaceuticals Quality Rank Related Terms

STU:2RY1
40GF Score
China SXT Pharmaceuticals Inc STU:2RY1
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China SXT Pharmaceuticals (STU:2RY1) Overvalued in 2026?

Based on GuruFocus' analysis, China SXT Pharmaceuticals stock appears to be undervalued. The current stock price of €384.00 is trading 83% below its estimated GF Value™ of €2,263.37.

Key valuation signals for STU:2RY1:

  • Quality Rank:
  • GF Value™: €2,263.37 vs. price of €384.00 (83% below fair value)
  • GF Score™: 40/100 with 8 warning signs

No single metric tells the full story. See the STU:2RY1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China SXT Pharmaceuticals Business Description

Other Exchanges SXTC:USA
Address No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
40GF Score

Get the complete analysis for STU:2RY1

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€384.00
Price
€2,263.37
GF Value